TLDR:
- L’Oréal’s venture capital arm, BOLD, has invested in Swiss consumer health company Timeline
- Timeline focuses on aging and longevity with its proprietary technology called Mitopure, which is incorporated into its line of supplements and topical skincare
- The funding will be used for expansion across food, beauty, and health sectors
- Longevity biotech has gained traction in the beauty industry, with companies such as Estée Lauder and OneSkin also focusing on this area
- L’Oréal believes that its investment in Timeline has the potential to bring the hallmarks of longevity to skin health and beauty
L’Oréal’s venture capital arm, BOLD (Business Opportunities for L’Oréal Development), has announced an investment in Swiss consumer health company Timeline. Timeline, which was founded in 2007, focuses on aging and longevity using its proprietary technology called Mitopure. This technology is incorporated into the company’s line of supplements and topical skincare products. The funding from L’Oréal will be used for expansion across the food, beauty, and health sectors.
Longevity biotech has become a growing focus in the beauty industry, with companies such as Estée Lauder and start-ups like OneSkin entering the market. Estée Lauder launched a new skin longevity platform in December 2023, while OneSkin uses longevity science to develop skincare products. L’Oréal believes that its investment in Timeline has the potential to bring the hallmarks of longevity to skin health and beauty.
This move by L’Oréal highlights the increasing interest in health and longevity in the beauty industry, as consumers seek products that not only enhance their appearance but also promote their overall well-being and longevity. By investing in Timeline, L’Oréal is positioning itself at the forefront of this emerging trend, potentially allowing the company to develop innovative skincare and beauty products that cater to these consumer demands.
Furthermore, this investment underscores L’Oréal’s commitment to research, innovation, and technology. The company has been working for a decade to understand and anticipate the impact of longevity on beauty. With the partnership with Timeline, L’Oréal aims to translate the breakthroughs in longevity research into practical applications for skin health and beauty.
This investment also demonstrates the increasing collaboration between beauty companies and biotech firms. As advancements in biotechnology continue to revolutionize the beauty industry, collaborations like this one could become more common. This could lead to the development of novel ingredients and formulations that address the aging process at a cellular level, offering consumers powerful and effective beauty solutions.
